Lisa Danzig
Direktor/Vorstandsmitglied bei OrSense Ltd.
Profil
Lisa Danzig is an Independent Director at OrSense Ltd.
and a Director at Karuna Foundation.
She was previously a Director at Avisa Pharma, Inc. and served as the Chief Medical Officer at Emergent Travel Health, Inc. from 2015 to 2018.
Danzig holds a doctorate degree from Oregon Health & Science University.
Aktive Positionen von Lisa Danzig
Unternehmen | Position | Beginn |
---|---|---|
OrSense Ltd.
OrSense Ltd. Medical DistributorsDistribution Services OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel. | Direktor/Vorstandsmitglied | - |
Karuna Foundation | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Lisa Danzig
Unternehmen | Position | Ende |
---|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2018 |
Avisa Pharma, Inc.
Avisa Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avisa Pharma, Inc. engages in the development of drug and device novel biomarker technology platform which enables the rapid detection of virulent bacterial pathogens within minutes. The company was founded by David Samuel Joseph in 2010 and is headquartered in Santa Fe, NM. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lisa Danzig
Oregon Health & Science University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
OrSense Ltd.
OrSense Ltd. Medical DistributorsDistribution Services OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel. | Distribution Services |
Karuna Foundation | |
Avisa Pharma, Inc.
Avisa Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avisa Pharma, Inc. engages in the development of drug and device novel biomarker technology platform which enables the rapid detection of virulent bacterial pathogens within minutes. The company was founded by David Samuel Joseph in 2010 and is headquartered in Santa Fe, NM. | Health Technology |